Brain & Nervous System Health Center
FDA OKs Generic Requip
May 14, 2008 -- The FDA has approved generic versions of the drug Requip made by four companies.
Generic ropinirole hydrochloride will be made by Teva Pharmaceuticals USA, Roxane Laboratories, Mylan Pharmaceuticals, and Par Pharmaceutical.
Requip, made by GlaxoSmithKline, is used to treat restless legs syndrome and Parkinson's disease. Requip's patent expires on May 19, according to the FDA.
Restless legs syndrome (RLS) is a disorder in which people have an unpleasant feeling in their legs when lying down to sleep; they often have a strong urge to move their legs, making it difficult to sleep.
Parkinson's is a progressive disease in which there is a breakdown in the nerve cells in the brain that make dopamine. Symptoms include tremors, stiff muscles, slow movement, and problems with balance or walking.
del.icio.us
Important Safety Information
Vimpat (lacosamide) is a medicine that is used with other medicines to treat partial onset seizures in patients 17 years of age and older with epilepsy. Vimpat is generally well-tolerated, but may not be for everyone. Ask your doctor if Vimpat is right for you. Antiepileptic drugs, including Vimpat, may cause suicidal thoughts or actions in a very small number of people, about 1 in 500. Call your healthcare provider right away if you have new or worsening symptoms of depression, any unusual changes in mood or behavior, or suicidal thoughts, behavior, or thoughts about self harm that you have never had before or may be worse than before. Please see additional patient information in the Medication Guide at the end of the full prescribing information. This information does not take the place of talking with your healthcare provider about your condition or your treatment. Please see additional Patient Safety Information
Brain & Nervous System Health Center
Many people experience dizzy spells, but how much is too much? Learn when dizzy equals danger.
